References
- Korrell M, Tanner C. Epidemiology of Parkinson’s disease: an overview. In: Parkinson’s Disease. Ebadi M, Pfeiffer RF (Eds). CRC Press, FL, USA 39–50 (2005).
- Clarke CE, Gullaksen E, Macdonald S, Lowe F. Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson’s disease. Acta Neurol. Scand.97(1), 27–35 (1998).
- Coates C, Bakheit AMO. Dysphagia in Parkinson’s disease. Eur. Neurol.38(1), 49–52 (1997).
- Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov. Disord.23(6), 837–844 (2008).
- Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov. Disord.20(2), 190–199 (2005).
- Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson’s disease. Acta Neurol. Scand.103(1), 7–11 (2001).
- Leow L, Huckabee M-L, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson’s disease as measured by the swallowing quality of life (SWAL-QOL) questionnaire. Dysphagia DOI: 10.1007/5.00455.009-9245-9 (2009) (Epub ahead of print).
- Plowman-Prine EK, Sapienza CM, Okun MS et al. The relationship between quality of life and swallowing in Parkinson’s disease. Mov. Disord.24(9), 1352–1358 (2009).
- Lorefält B, Granérus A, Unosson M. Avoidance of solid food in weight losing older patients with Parkinson’s disease. J. Clin. Nurs.15(11), 1404–1412 (2006).
- Nagaya M, Kachi T, Yamada T. Effect of swallowing training on swallowing disorders in Parkinson’s disease. Scand. J. Rehabil. Med.32(1), 11–15 (2000).
- Ertekin C, Tarlaci S, Aydogdu I et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov. Disord.17(5), 942–949 (2002).
- Muller J, Wenning GK, Verny M et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch. Neurol.58(2), 259–264 (2001).
- Potulska A, Friedman A, Krolicki L, Spychala A. Swallowing disorders in Parkinson’s disease. Parkinsonism Relat. Disord.9(6), 349–353 (2003).
- Miller N, Allcock L, Hildreth AJ et al. Swallowing problems in Parkinson disease: frequency and clinical correlates. J. Neurol. Neurosurg. Psychiatry80(9), 1047–1049 (2009).
- Paolo B, Angelo A, Carlo C et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov. Disord.24(11), 1641–1649 (2009).
- Baijens LWJ, Speyer R. Effects of therapy for dysphagia in Parkinson’s disease: systematic review. Dysphagia24(1), 91–102 (2009).
- Deane KH, Whurr R, Clarke CE, Playford ED, Ben-Shlomo Y. Non-pharmacological therapies for dysphagia in Parkinson’s disease. Cochrane Database Syst. Rev.1, CD002816 (2001).
- Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson’s disease. Neurology39(10), 1309–1314 (1989).
- Hunter PC, Crameri J, Austin S, Woodward MC, Hughes AJ. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J. Neurol. Neurosurg. Psychiatry63(5), 579–583 (1997).
- Lim A, Leow L, Huckabee ML, Frampton C, Anderson T. A pilot study of respiration and swallowing integration in Parkinson’s disease: “On” and “Off” levodopa. Dysphagia23(1), 76–81 (2008).
- Bartels AL, Leenders KL. Parkinson’s disease: the syndrome, the pathogenesis and pathophysiology. Cortex45(8), 915–921 (2009).
- Picconi B, Centonze D, Hakansson K et al. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci.6(5), 501–506 (2003).
- Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat. Rev. Neurosci.2(8), 577–588 (2001).
- Clarke CE. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson’s disease. Lancet Neurol.3(8), 466–474 (2004).
- Poewe W, Mahlknecht P. The clinical progression of Parkinson’s disease. Parkinsonism Relat. Disord.15(Suppl. 4), S28–S32 (2009).
- Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of levodopa on speech in Parkinson’s disease. Mov. Disord.23(4), 574–580 (2008).
- Shill H, Stacy M. Respiratory function in Parkinson’s disease. Clin. Neurosci.5(2), 131–135 (1998).
- Brown LK. Respiratory dysfunction in Parkinson disease. Clin. Chest Med.15(4), 715–727 (1994).
- Gross RD, Atwood CW, Ross SB et al. The coordination of breathing and swallowing in Parkinson’s disease. Dysphagia23(2), 136–145 (2008).
- Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K. Pattern of subclinical pulmonary dysfunctions in Parkinson’s disease and the effect of levodopa. Mov. Disord.22(3), 420–424 (2007).
- Debruin PF, Debruin VM, Lees AJ, Pride NB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson’s disease. Am. Rev. Respir. Dis.148(6), 1576–1580 (1993).
- Troche M, Sapienza C, Rosenbek J. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson’s disease. Dysphagia23(1), 26–32 (2008).
- Russell JA, Ciucci MR, Connor NP, Schallert T. Targeted exercise therapy for voice and swallow in persons with Parkinson’s disease. Brain Res. DOI: 10.1016/j.brainres.2010.03.029 (2010) (Epub ahead of print).
- Pitts T, Bolser D, Rosenbek J et al. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest135(5), 1301–1308 (2009).
- Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson’s disease. N. Engl. J. Med.346(15), 1174–1175 (2002).
- Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson’s disease: results of a randomized, blinded pilot study. Neurosurgery45(6), 1375–1382; discussion 1382–1384 (1999).
- Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov. Disord.23(5), 676–683 (2008).
- Manor Y, Balas M, Giladi N, Mootanah R, Cohen JT. Anxiety, depression and swallowing disorders in patients with Parkinson’s disease. Parkinsonism Relat. Disord.15(6), 453–456 (2009).